BIOVECTRA’s Post

How can #LabChip lead to better biologics and a better understanding of biologic samples? ❗ This paper documents a high-throughput approach to 2-dimensional protein separation. By combining strong anion exchange chromatography (SAX-HPLC) and Capillary-Electrophoresis with SDS (#CE-SDS), the authors quantify proteins from cell lysates and human serum. With this approach, datasets that would normally take days to gather can be analyzed in an afternoon! ❗❗ See the full text here: https://lnkd.in/gDMynSUQ #celllinedevelopment #microfluidics #antibodies #revvity #biologics #processdevelopment

Programmable medicines hold immense significance as they embody drugs designed with customizable features and functions. Crafted using biological 'programming languages,' these medicines allow for precise design and execution, revolutionizing the way we approach medical treatments. At Constructive Bio, we specialize in creating programmable medicines, utilizing a vast array of building blocks. Our approach is grounded in the 'recoded life method,' which is renowned for its unprecedented fidelity, specificity, and scalability, enabling us to pioneer new frontiers in medical treatment. Non-canonical building blocks are crucial because they serve as the carriers of desirable characteristics. Discover the underlying concept driving the latest advancements in precision biologics and biomolecule innovation by reading below.

Check out our latest #blog featuring Eric Miller to learn how our new and innovative solution- LabZient™, was designed to revolutionize the assessment and validation process of large molecules like antibodies and bioconjugates. Eric shares, "By employing predictable and standardized methods, LabZient™ not only hastens the journey towards an IND application but also boosts overall efficiency and reduces risks. This is particularly advantageous for biotech companies aiming for rapid market entry, as it enables them to navigate the development process more swiftly and effectively." Access the article: https://lnkd.in/gPkrrBPc #analyticalmethoddevelopment #CDMO #biologics #antibodies

Everyone wants biotherapeutics that are efficacious, stable, and easy to produce. Too bad this doesn't just happen on its own... How can scientists engineer their biologics to meet those criteria? Let's look at an example! ❗ A team from Pfizer utilized #FcFusion technology and #glycanengineering to significantly enhance the production profile, efficacy, and in-serum stability of a GDF-15 protein to treat weight loss. ❗ ❗ Side Note: While engineering the glycosylation profile of their mutants, they used the #LabChip GXII Touch from Revvity to quickly measure glycan occupancy and profile. ❗ ❗ ❗ Check out the full text here: https://lnkd.in/gaU4CwXm #biologics #revvity #proteinengineering #capillary #electrophoresis #antibodies #fusion #glycans #medicine #structuralbiology

If you're interested in reading about the #labChip capabilities for Proteomics, check out this publication below by one of our Revvity #labchip experts! 😃 #LabChip #innovation #microfluidics #proteomics #lifescience #revvity

At last month's American Biomanufacturing Summit, our Sr. Director of MSAT, Dennis Yoon, presented on Abzena's approach to scaling up and manufacturing biologics in: "Navigating a Complex Downstream #Manufacturing Strategy to Ensure Clinical & Commercial Success." From the importance of an established routine to the required expertise, process trains, and single-use technologies, he offered insights into what is needed to establish a solid foundation for success for your antibody. If you're starting to plan for your clinical or commercial manufacturing program, connect with our team today to learn how we can seamlessly take your biologic from benchtop to commercial scale manufacturing: https://lnkd.in/gKDnVFEB #CDMO #CRO #biologics #drugsubstance

Each drug's unique biochemistry calls for a tailored approach. We understand that biotech companies face challenges like stability, aggregation, and interaction with excipients. Paired with a biophysical approach that provides greater accuracy in predictions, the Tanvex platform stands out by predicting potential hurdles and enabling rapid, informed decision-making. Read how Tanvex CDMO is revolutionizing formulation development and contributing to the accelerated timelines of drug development in Pawel Stanczak's article: https://lnkd.in/eVuKyqjH #biologics #cdmo #pharmaindustry #lifesciences

We are excited to be a part of Festival of Biologics scheduled on 10-12 October at Basel, Switzerland. Meet Ajay Babu Gopaluni, Senior Manager, Business Development, at booth #200 to understand how Aragen can partner with you in overcoming your drug discovery challenges. With nearly three decades of experience, we deliver integrated and standalone solutions for large molecules from our research facilities located in California, USA. Our expertise spans Cell Line Development, offering royalty-free CHO platforms, and comprehensive antibody discovery services. Our proprietary RapTr2022 platform is best suited to produce difficult-to-express proteins and has a strong track record of successfully engineering cell lines for timely delivery of more than 100 CLD projects, majority of which have resulted in IND applications. We provide upstream and downstream services, optimizing media, assessing developability, and characterizing products. Aragen's advanced analytics enhance quality, mitigate risk, and expedite timelines for recombinant proteins. Write to us at bd@aragen.com to schedule a meeting during the event to discuss how we can partner with you in accelerating your projects. #FestivalofBiologics #Biologics #LargeMolecule #AntibodyDiscovery #Development #CellLineDevelopment #ProcessDevelopmet #Downstream #Upstream #Aragen #AragenLifeSciences #Basel #Switzerland

Assessment of CQA in mRNA-LNP modality is essential to ensure product quality. They can influence: 🔹 Potency 🔹 Stability 🔹 Toxicity 🔹 Risk assessment relevant to mRNA-LNP modality This white paper is the first of a 3-part series written in partnership with CATUG. Stay tuned to learn more about ADC’s and mAb’s later in this series. For more information, visit: https://lnkd.in/eeg42_hj #CrystalBio #CATUGCrystal #CrystalPharmatech #CATUG #PharmaceuticalScience #Biologics #CMC #Biotech #DrugDevelopment #Research #Technology #API #CRO #CDMO

It’s good to see the analytical approaches to assess CQA under regulatory guidance.